Relapsed/Refractory HER2+ Metastatic Breast Cancer
February 15th 2021Recommendations for managing 2 patient cases specific to HER2-positive metastatic breast cancer and optimizing therapy for specific patient populations within the HER2-positive space based on emerging treatments and changes to standards of care.